%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2021-05-12T11:34:48-04:00
2021-05-12T11:34:54-04:00
2021-05-12T11:34:54-04:00
Adobe InDesign CC 13.1 (Windows)
uuid:0c6c03c4-979e-4cd3-a4d0-5dac6bc9016b
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
xmp.id:ee00b423-ae1d-ad41-ac2c-356c1d68692e
proof:pdf
xmp.iid:5e47f2be-ed4f-3043-814a-1f1f0e7f183c
xmp.did:32bfdc11-6cee-224b-a991-0422b36ac1d4
xmp.did:4A42F9656056E111960DCE8E95F0DF9D
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 13.1 (Windows)
/
2021-05-12T11:34:48-04:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
12 0 obj
<>
endobj
3 0 obj
<>
endobj
5 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
6 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/Properties<>/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
14 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 612.0 792.0]/Type/Page>>
endobj
47 0 obj
<>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc 8.5 0 0 8.5 171.2281 389.438 Tm
(1.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(His bundle pacing compared to biventricular)-10 ( )]TJ
0 -1.2 Td
[(pacing for cardiac resynchronization therapy)-10 ( )]TJ
0 -1.2 Td
(in heart failure patients results in:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. shorter procedure times.)Tj
0 -1.729 Td
[(b. improved New Y)86 (ork Heart Association )]TJ
0 -1.2 Td
(class. )Tj
0 -1.729 Td
(c. higher pacing thresholds.)Tj
0 -1.729 Td
(d. longer six-minute walk distance.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(2.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(A population-based study of patients with)-10 ( )]TJ
0 -1.2 Td
[(diseases of the aorta showed \037uoroquinolone)-10 ( )]TJ
0 -1.2 Td
[(antibiotics use compared to ampicillin use)-10 ( )]TJ
0 -1.2 Td
(resulted in:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. increased all-cause mortality rate.)Tj
0 -1.729 Td
(b. fewer aortic surgery cases.)Tj
0 -1.729 Td
(c. fewer infection relapses.)Tj
0 -1.729 Td
(d. lower aortic disease mortality rate.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(3.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Acute ST)92 (-elevation myocardial infarction in)-10 ( )]TJ
0 -1.2 Td
[(post-transcatheter aortic valve replacement)-10 ( )]TJ
0 -1.2 Td
(patients is associated with:)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. rupture of prior nonocclusive plaques.)Tj
0 -1.729 Td
(b. coronary artery dissection. )Tj
22.896 32.682 Td
(c. a higher rate of coronary intervention )Tj
0 -1.2 Td
(failure.)Tj
0 -1.729 Td
(d. perivalvular regurgitation.)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(4.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(Which symptom during long-term implantable)-10 ( )]TJ
0 -1.2 Td
[(loop ECG recorders was associated with)-10 ( )]TJ
0 -1.2 Td
(episodes of atrial \036brillation?)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. Dizziness)Tj
0 -1.729 Td
(b. Syncope)Tj
0 -1.729 Td
(c. Dyspnea)Tj
0 -1.729 Td
(d. Palpitation)Tj
/CS0 cs 1 scn
/GS0 gs
/T1_0 1 Tf
-0.01 Tc -1.588 -2.894 Td
(5.)Tj
/Span<>> BDC
[( )-94.4 ( )]TJ
EMC
1.588 0 Td
[(In patients undergoing transesophageal)-10 ( )]TJ
0 -1.2 Td
[(echocardiography before elective cardioversion)-10 ( )]TJ
0 -1.2 Td
[(who were not adequately anticoagulated,)-10 ( )]TJ
0 -1.2 Td
(which reduced the risk of thromboemboli?)Tj
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
0 Tc 0 -1.729 Td
(a. Large left atrium)Tj
0 -1.729 Td
(b. Moderate or severe mitral regurgitation)Tj
0 -1.729 Td
(c. Reduced left ventricular ejection fraction)Tj
0 -1.729 Td
(d. A high CHA)Tj
4.9555 0 0 4.9555 435.0702 143.9075 Tm
(2)Tj
8.5 0 0 8.5 437.8254 146.738 Tm
(DS)Tj
4.9555 0 0 4.9555 448.6884 143.9075 Tm
(2)Tj
8.5 0 0 8.5 451.4437 146.738 Tm
[(-V)105 (ASc score)]TJ
-0.01 Tc 10 0 0 10 163.2662 733.8799 Tm
[(population using the REVEAL AF entry)-10 ( )]TJ
0 -1.229 Td
[(criteria would be. In this regard, the Reiffel)-10 ( )]TJ
0 -1.229 Td
(et al substudy adds another possible selec)Tj
0 Tc (-)Tj
-0.01 Tc 0 -1.229 Td
[(tion criterion: palpitation. This makes sense)-10 ( )]TJ
0 -1.229 Td
[(since one would predict more AF would)-10 ( )]TJ
0 -1.229 Td
[(be discovered in such patients compared to)-10 ( )]TJ
0 -1.229 Td
[(those without. However)111 (, REVEAL AF also)-9.9 ( )]TJ
0 -1.229 Td
[(showed palpitation was more common in)-10 ( )]TJ
0 -1.229 Td
[(those without SAF)129.1 (, even though it was the)-9.9 ( )]TJ
0 -1.229 Td
(only symptom predictive of SAF in a multi)Tj
0 Tc (-)Tj
-0.01 Tc 0 -1.229 Td
[(variate analysis. Thus, even the presence of)-9.9 ( )]TJ
0 -1.229 Td
[(palpitation may not be selective enough to)-10 ( )]TJ
0 -1.229 Td
(warrant prolonged invasive monitoring.)Tj
0 -2.459 Td
[(In addition to its post-hoc, retrospective)-10 ( )]TJ
0 -1.229 Td
[(design, there were other limitations to this)-10 ( )]TJ
0 -1.229 Td
[(substudy)92 (. Symptom collection happened)-10 ( )]TJ
0 -1.229 Td
[(before the monitoring period only)92 (. It)-10 ( )]TJ
0 -1.229 Td
[(is unclear whether the symptoms were)-10 ( )]TJ
0 -1.229 Td
[(associated with the actual SAF events.)-10 ( )]TJ
0 -1.229 Td
[(Palpitation could be the result of other)-9.9 ( )]TJ
0 -1.229 Td
[(events, such as re-entrant supraventricular)-9.9 ( )]TJ
0 -1.229 Td
[(tachycardia or even ventricular tachycardia.)-10 ( )]TJ
0 -1.229 Td
[(Many patients reported more than one)-9.9 ( )]TJ
20.299 28.276 Td
[(symptom, yet the authors did not conduct a)-10 ( )]TJ
0 -1.203 Td
[(combination symptoms analysis. Also, they)-10 ( )]TJ
0 -1.203 Td
[(did not perform an analysis of the added)-10 ( )]TJ
0 -1.203 Td
[(value of palpitation to other clinical risk)-9.9 ( )]TJ
0 -1.203 Td
[(factors for AF)129.1 (. Consequently)92 (, at this point,)-10 ( )]TJ
0 -1.203 Td
(it is certainly reasonable to conduct short-)Tj
0 -1.203 Td
[(term external monitoring in patients with)-10 ( )]TJ
0 -1.203 Td
[(frequent arrhythmia-compatible symptoms)-10 ( )]TJ
0 -1.203 Td
[(and perhaps discuss an implantable)-10 ( )]TJ
0 -1.203 Td
[(loop recorder in those with less frequent)-10 ( )]TJ
0 -1.203 Td
[(symptoms. However)111 (, moving to implanting)-10 ( )]TJ
0 -1.203 Td
[(loop recorders in patients with only AF)-9.9 ( )]TJ
0 -1.203 Td
[(risk factors is an unproven way to reduce)-10 ( )]TJ
0 -1.203 Td
[(the morbidity and mortality of AF)129 (. This)-9.9 ( )]TJ
0 -1.203 Td
[(substudy of REVEAL AF does not establish)-10 ( )]TJ
0 -1.203 Td
[(that the additional presence of palpitation)-10 ( )]TJ
0 -1.203 Td
[(with risk factors for AF tips the balance)-10 ( )]TJ
0 -1.203 Td
[(toward implanting a loop recorder)111 (. )-10 ( )]TJ
/C2_0 1 Tf
0 Tc 15.331 0 Td
<0084>Tj
/TT0 1 Tf
0.01 Tc -0.01 Tw 9.25 0 0 9.25 366.2537 506.2783 Tm
(REFERENCE)Tj
/TT1 1 Tf
-0.025 Tc 0 Tw 0 -1.193 Td
(1.)Tj
/Span<>> BDC
( )Tj
EMC
1.946 0 Td
[(R)17.5 (eiffel JA, V)54.8 (erma A, K)17.6 (owey PR, et al. Incidence of)-25 ( )]TJ
0 -1.193 Td
(previously undiagnosed atrial fibrillation using insert)Tj
0 Tc (-)Tj
-0.025 Tc 0 -1.193 Td
[(able cardiac monitors in a high-risk population: The)-25.1 ( )]TJ
0 -1.193 Td
[(REVEAL AF study)87 (. )]TJ
/TT2 1 Tf
(JAMA Cardiol)Tj
/TT1 1 Tf
( 2017;2:)Tj
0 Tc 14.355 0 Td
( )Tj
-0.025 Tc 0.025 Tw -14.355 -1.193 Td
(1120-1127.)Tj
ET
endstream
endobj
49 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
/CS0 cs 0.07 scn
/GS0 gs
18 99.617 120.33 656.383 re
f
18 36 539.325 53.473 re
f
BT
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 7 0 0 7 27.8983 78.3659 Tm
(Interested in reprints or posting an article to your )Tj
0 -1.143 Td
[(company)-55.8 (\222s site? There are numerous opportunities for )]TJ
0 -1.143 Td
(you to leverage editorial recognition for the benefit of )Tj
0 -1.143 Td
(your brand. Call us at \(800\) 688-2421 or email us at )Tj
0 -1.143 Td
(reliasmedia)Tj
/C2_0 1 Tf
<0014>Tj
/TT0 1 Tf
(@gmail.com.)Tj
25.217 4.571 Td
(Discounts are available for group subscriptions, multiple )Tj
0 -1.143 Td
(copies, site licenses, or electronic distribution. For pricing )Tj
0 -1.143 Td
(information, please contact our Group Account Managers )Tj
0 -1.143 Td
(at groups@reliasmedia.com or \(866\) 213-0844.)Tj
19.248 0 Td
( )Tj
5.969 3.429 Td
[(T)175 (o reproduce any part of R)17.6 (elias Media newsletters for )]TJ
0 -1.143 Td
(educational purposes, please contact The Copyright )Tj
0 -1.143 Td
(Clearance Center for permission at info@copyright.com )Tj
0 -1.143 Td
(or \(978\) 750-8400.)Tj
ET
/CS0 CS 1 SCN
3 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 138.6633 754.5 cm
0 0 m
437.337 0 l
S
Q
/CS0 cs 1 scn
163.328 405.32 392.414 17.367 re
f
0.25 w
163.391 99.742 392.225 305.133 re
S
BT
0 0 0 0 k
12 0 0 12 304.0168 409.4156 Tm
(CME/CE QUESTIONS)Tj
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
7 0 0 7 26.64 742.5959 Tm
(PHYSICIAN EDITOR)Tj
( )Tj
/TT0 1 Tf
0 -1.214 Td
[(Michael H)17.9 (. Crawford, MD)]TJ
/TT1 1 Tf
0 -1.214 Td
[(P)35.7 (rofessor of Medicine)]TJ
0 -1.214 Td
[(L)17.4 (ucy Stern Chair in Cardiology)]TJ
0 -1.214 Td
(University of California)Tj
0 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/T1_0 1 Tf
0 -2.429 Td
(PEER REVIEWER)Tj
/TT0 1 Tf
0 -1.214 Td
(Susan Zhao, MD)Tj
/TT1 1 Tf
0 -1.214 Td
(Director )Tj
( )Tj
0 -1.214 Td
[(Adult Echocardiography L)17.3 (aboratory)]TJ
0 -1.214 Td
(Associate Chief)Tj
5.804 0 Td
( )Tj
-5.804 -1.214 Td
(Division of Cardiology)Tj
8.454 0 Td
( )Tj
-8.454 -1.214 Td
(Department of Medicine)Tj
0 -1.214 Td
[(Santa Clara V)53.9 (alley Medical Center)]TJ
/T1_0 1 Tf
0 -2.429 Td
(NURSE PLANNER)Tj
/TT0 1 Tf
0 -1.214 Td
[(Aurelia Macabasco)-18.9 (-)-36.5 (O)17.8 (\222Connell, PhD, )]TJ
0 -1.214 Td
[(A)17.5 (CNP)78 (-BC, RN, PHN, F)36.7 (AHA)]TJ
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor)]TJ
0 -1.214 Td
[(Azusa P)54.6 (acific University )]TJ
9.021 0 Td
( )Tj
-9.021 -1.214 Td
(School of Nursing)Tj
/T1_0 1 Tf
0 -2.715 Td
[(EDITORIAL ADVISOR)92.1 (Y BOARD)]TJ
/TT0 1 Tf
0 -1.214 Td
[(Jamie L. W)123.9 (. K)17.8 (ennedy)87.4 (, MD, F)35.6 (A)17.5 (CC)]TJ
( )Tj
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor)]TJ
( )Tj
0 -1.214 Td
(Division of Cardiology)Tj
8.454 0 Td
( )Tj
-8.454 -1.214 Td
[(Advanced Heart F)35.4 (ailure )]TJ
( )Tj
0 -1.214 Td
[(& T)155.6 (ransplant Cardiology)]TJ
9.12 0 Td
( )Tj
-9.12 -1.214 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/TT0 1 Tf
0 -2.429 Td
(Joshua D. Moss, MD)Tj
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor )]TJ
( )Tj
0 -1.214 Td
(of Clinical Medicine)Tj
0 -1.214 Td
(Cardiac Electrophysiology)Tj
0 -1.214 Td
(Division of Cardiology)Tj
0 -1.214 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.214 Td
[(San F)54.9 (rancisco)]TJ
/TT0 1 Tf
0 -2.429 Td
(Jeffrey Zimmet, MD, PhD)Tj
/TT1 1 Tf
0 -1.214 Td
[(Associate P)35.3 (rofessor of Medicine)]TJ
0 -1.214 Td
(University of California)Tj
8.642 0 Td
( )Tj
-8.642 -1.214 Td
[(San F)54.9 (rancisco)]TJ
0 -1.214 Td
[(Director)100.5 (, Cardiac )]TJ
6.807 0 Td
( )Tj
-6.807 -1.214 Td
[(Catheterization L)16.4 (aboratory)]TJ
0 -1.214 Td
[(San F)54.9 (rancisco V)54.9 (A Medical Center)]TJ
/T1_0 1 Tf
0 -2.429 Td
(EDITOR)Tj
/TT1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 Td
(Jonathan Springston)Tj
/T1_0 1 Tf
0 -2.429 Td
(EDITOR)Tj
/TT1 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 Td
(Jason Schneider)Tj
/T1_0 1 Tf
0 -2.429 Td
(EDITORIAL GROUP MANAGER)Tj
/TT0 1 Tf
0 -1.214 Td
(Leslie Coplin)Tj
/T1_0 1 Tf
0 -2.429 Td
[(ACCREDIT)74.1 (A)74 (TIONS DIRECTOR)]TJ
/TT2 1 Tf
( )Tj
/TT0 1 Tf
0 -1.214 Td
(Amy M. Johnson, MSN, RN, CPN)Tj
ET
endstream
endobj
50 0 obj
<>
endobj
51 0 obj
<>
endobj
52 0 obj
<>
endobj
53 0 obj
<>
endobj
54 0 obj
<>
endobj
63 0 obj
<>
endobj
64 0 obj
<>stream
H|yTTGƿۯfdh1FhdF'FMT¢"(*q
7ZEqwEŽ[4nQQc<:ICT?:VwoUW@$tڴEχCX߸ԃ~(
ˋf2k.ARRz
4
<*ưXv1?Blh7ТЭGHBO:J/|"yp\,|w1Wn;2N~+po0-oe}<4Xo